Gene · 126328
Papers357
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 357
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma. | Sci Prog | 2026 | 42370567 | PubTator, text mining | PubMed |
| Disulfidptosis-related genes define a prognostic signature and novel therapeutic targets in Ewing's sarcoma through transcriptomic analysis and experimental validation. | Front Immunol | 2026 | 42064080 | PubTator, text mining | PubMed |
| Parkinson's Disease: From Metabolism to Genetics-A Comprehensive Review. | Curr Issues Mol Biol | 2026 | 41899406 | PubTator, text mining | PubMed |
| A genus-wide interaction atlas across NS4B orthologues identifies a conserved role for UFMylation in orthoflavivirus replication. | Nat Commun | 2026 | 41826287 | PubTator, text mining | PubMed |
| Mitochondrial abnormalities in idiopathic inflammatory myopathies. | Clin Exp Rheumatol | 2026 | 41738252 | PubTator, text mining | PubMed |
| Machine learning identifies disulfidptosis-related gene signature for pancreatic cancer prognosis and immune infiltration. | Discov Oncol | 2026 | 41591656 | PubTator, text mining | PubMed |
| Integrated proteomics and metabolomics reveal phytosesquiterpene lactones inhibit TNBC cell activity by depleting ATP synthesis and reprogramming primary metabolism. | Sci Rep | 2026 | 41530404 | PubTator, text mining | PubMed |
| Prediction of the Prognosis and Treatment Responses Based on the Characteristics of Disulfidptosis-Related Genes in Patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma | Endocr Metab Immune Disord Drug Targets | 2026 | 39945255 | PubTator, text mining | PubMed |
| Mitochondrial energy metabolism genes as prognostic biomarkers in clear cell renal cell carcinoma via single-cell and bulk RNA sequencing analyses. | Discov Oncol | 2025 | 41364140 | PubTator, text mining | PubMed |
| Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. | Chin J Cancer Res | 2025 | 41246257 | PubTator, text mining | PubMed |
Mechanisms of metformin in alleviating neurological deficits in stroke patients: Involving Ndufa11-mediated mitochondrial protection, enhanced neuronal electrophysiology, and inhibition of disulfidptosis. | Brain Res Bull | 2025 | 41236076 | PubTator, text mining | PubMed |
| Proteomic profiling of bone tissue reveals distinct pathways in men and women with osteoporosis. | Age Ageing | 2025 | 41104785 | PubTator, text mining | PubMed |
| Identification of an E2Fs-based gene signature for predicting prognosis and therapeutic response in colorectal cancer. | Discov Oncol | 2025 | 41091262 | PubTator, text mining | PubMed |
| Disulfidptosis OXSM serves as a potential prognostic biomarker and correlates with immune infiltrates in glioma. | Discov Oncol | 2025 | 41003892 | PubTator, text mining | PubMed |
| Metformin alters mitochondria-related metabolism and enhances human oligodendrocyte function. | Nat Commun | 2025 | 40885740 | PubTator, text mining | PubMed |
| Endo180 and basement membrane stiffness induce OXPHOS and neoplastic transformation in aging prostate epithelia. | NPJ Aging | 2025 | 40753084 | PubTator, text mining | PubMed |
| De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. | Nat Commun | 2025 | 40738904 | PubTator, text mining | PubMed |
| Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy. | J Inflamm Res | 2025 | 40735269 | PubTator, text mining | PubMed |
| Investigating the role of disulfidoptosis in spinal cord injury and development of a novel diagnostic model. | Acta Orthop Traumatol Turc | 2025 | 40726387 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals the molecular mechanism of silibinin rescue the toxic effects of butyl benzyl phthalate on porcine preimplantation embryos. | J Hazard Mater | 2025 | 40554343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/126328/papers